共 50 条
- [21] A Phase 2a Study of DP2 Antagonist GB001 for Asthma JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (04): : 1275 - +
- [30] Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (02): : 255 - 257